Your browser doesn't support javascript.
loading
Chronic stimulation with SARS-CoV-2 spike protein does not trigger autoimmunity.
Scherlinger, Marc; Sibilia, Jean; Tsokos, George C; Gottenberg, Jacques-Eric.
Affiliation
  • Scherlinger M; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University Hospital, Strasbourg University, France; Laboratoire d'ImmunoRhumatologie Molécul
  • Sibilia J; Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University Hospital, Strasbourg University, France; Laboratoire d'ImmunoRhumatologie Moléculaire, Institut national de la santé et de la recherche médicale (INSERM) UMR_S
  • Tsokos GC; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Gottenberg JE; Rheumatology department, Centre national de référence maladie auto-immunes et systémiques rares Est/Sud-Ouest (RESO), Strasbourg University Hospital, Strasbourg University, France; Immunologie, Immunopathologie et Chimie Thérapeutique (I2CT)-UPR3572 CNRS, Institut de Biologie Moléculaire et Cellulai
Clin Immunol ; 248: 109264, 2023 03.
Article in En | MEDLINE | ID: mdl-36804225
Autoimmune manifestations were reported in people infected with SARS-CoV-2. Repetitive exposure of mice to foreign antigen may lead to the onset of autoimmunity. We therefore investigated whether repetitive exposure to the SARS-CoV-2 spike protein could result in autoimmunity. To address this hypothesis, we repeatedly immunized C57Bl/6 mice with spike protein injected intraperitoneally. At the end of the immunization, mice which received spike protein produced anti-spike IgG but none of them developed anti-dsDNA antibodies or proteinuria. In conclusion, repetitive immunization with SARS-CoV-2 spike protein does not induce autoimmunity in the present mice model. Albeit reassuring, these results need to be confirmed by large epidemiological study evaluating the incidence of autoimmune diseases in individuals with repetitive SARS-CoV-2 antigen exposure.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Limits: Animals / Humans Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Limits: Animals / Humans Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2023 Type: Article